製品: HEPACAM Antibody
カタログ: DF12075
タンパク質の説明: Rabbit polyclonal antibody to HEPACAM
アプリケーション: WB IHC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog
分子量: 46-72 kDa(Observed); 46kD(Calculated).
ユニプロット: Q14CZ8
RRID: AB_2844880

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human, Mouse, Rat
予測:
Pig(100%), Zebrafish(%), Bovine(%), Horse(%), Sheep(%), Rabbit(%), Dog(%)
クローナリティ:
Polyclonal
特異性:
HEPACAM Antibody detects endogenous levels of total HEPACAM.
RRID:
AB_2844880
引用形式: Affinity Biosciences Cat# DF12075, RRID:AB_2844880.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

FLJ25530; GlialCAM; HECAM_HUMAN; HEPACAM; Hepatocyte cell adhesion molecule; Protein hepaCAM;

免疫原

免疫原:

A synthesized peptide derived from human HEPACAM, corresponding to a region within C-terminal amino acids.

Uniprot:
遺伝子(ID):
タンパク質配列:
MKRERGALSRASRALRLAPFVYLLLIQTDPLEGVNITSPVRLIHGTVGKSALLSVQYSSTSSDRPVVKWQLKRDKPVTVVQSIGTEVIGTLRPDYRDRIRLFENGSLLLSDLQLADEGTYEVEISITDDTFTGEKTINLTVDVPISRPQVLVASTTVLELSEAFTLNCSHENGTKPSYTWLKDGKPLLNDSRMLLSPDQKVLTITRVLMEDDDLYSCMVENPISQGRSLPVKITVYRRSSLYIILSTGGIFLLVTLVTVCACWKPSKRKQKKLEKQNSLEYMDQNDDRLKPEADTLPRSGEQERKNPMALYILKDKDSPETEENPAPEPRSATEPGPPGYSVSPAVPGRSPGLPIRSARRYPRSPARSPATGRTHSSPPRAPSSPGRSRSASRTLRTAGVHIIREQDEAGPVEISA

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Rabbit
100
Zebrafish
80
Xenopus
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation.

PTMs:

N-glycosylated.

細胞の位置付け:

Cytoplasm. Membrane>Single-pass type I membrane protein>Cytoplasmic side.
Note: In MCF-7 breast carcinoma and hepatic Hep 3B2.1-7 and Hep-G2 cell lines, localization of HEPACAM is cell density-dependent. In well spread cells, localized to punctate structures in the perinuclear membrane, cytoplasm, and at cell surface of protusions. In confluent cells, localized predominantly to the cytoplasmic membrane, particularly in areas of cell-cell contacts. Colocalizes with CDH1.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
タンパク質ファミリー:

The cytoplasmic domain plays an important role in regulation of cell-matrix adhesion and cell motility.

参考文献

1). Astroglial exosome HepaCAM signaling and ApoE antagonization coordinates early postnatal cortical pyramidal neuronal axon growth and dendritic spine formation. Nature communications, 2023 (PubMed: 37620511) [IF=16.6]

Application: WB    Species: Mouse    Sample:

Fig. 2 Involvement of A-Exo. surface signals in promoting axon growth and identification of the surface expression of HepaCAM (GlialCAM) on A-Exo. Representative images (a) and quantification (b) of axon length of cortical neurons in control (i) or treated with proteinase K (10 μg/ml, 5 min) digested A-Exo. (ii) sonicated (30 s) and proteinase K digested A-Exo. (iii) A-Exo. (iv) sonicated A-Exo. (v) or sonicated (30 s) and RNase (10 μg/ml, 5 min) digested A-Exo. (vi) 1 μg A-Exo./sample was used in each treatment in (a, b). White arrows: elongated axons; Number of neurons quantified in each group shown in the graph (6–11 neurons/replicate, 3 biological replicates)/group; Scale bar: 100 μm; Representative images (c) and quantification (d) of axon length of cortical neurons plated on either poly-D-lysine (PDL) coated or PDL/A-Exo. coated coverslips. Number of neurons quantified in each group shown in the graph (10–11 neurons/replicate, 3 biological replicates)/group; Scale bar: 100 μm; e Quantification of axon length of cortical neurons following A-Exo. treatment or co-treatment with A-Exo. and dynasore (dynamin inhibitor, 50 μM). n = 22 (control) or 21 (A-Exo. and A-Exo. + dynasore) neurons (6–7 neurons/replicate, 3 biological replicates)/group; f Proteomic identification of different categories of transmembrane proteins on A-Exo. surface. Specific transmembrane proteins are included in Supplementary Table 1. n = 3 biological replicates; g Detection of specific HepaCAM immunoreactivity (>5 replicates) from spinal cord lysate (10 μg/lane), astrocyte lysate (10 μg/lane), and A-Exo. (1 μg/lane) prepared from WT (+/+), HepaCAM heterozygous (+/−), and HepaCAM KO (−/−) mice; Red arrow: specific HepaCAM immunoreactivity; Black arrow: non-specific immunoreactivity; h Detection of specific HepaCAM immunoreactivity (>5 replicates) in A-Exo. but not in exosome-free ACM fractions; 1 μg A-Exo. was used in each experiment. p value in (d) determined from two-tailed t-test; p values in (b, e) determined by one-way ANOVA followed by post hoc Tukey’s test. Data are presented as mean values ± SEM.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.